126 related articles for article (PubMed ID: 20167695)
21. Plasma methylphenidate concentrations in youths treated with high-dose osmotic release oral system formulation.
Stevens JR; George RA; Fusillo S; Stern TA; Wilens TE
J Child Adolesc Psychopharmacol; 2010 Feb; 20(1):49-54. PubMed ID: 20166796
[TBL] [Abstract][Full Text] [Related]
22. Methylphenidate bioavailability from two extended-release formulations.
González MA; Pentikis HS; Anderl N; Benedict MF; DeCory HH; Dirksen SJ; Hatch SJ
Int J Clin Pharmacol Ther; 2002 Apr; 40(4):175-84. PubMed ID: 11996212
[TBL] [Abstract][Full Text] [Related]
23. Stereoselective urinary pharmacokinetics of dl-threo-methylphenidate and its major metabolite in humans.
Srinivas NR; Hubbard JW; Korchinski ED; Midha KK
J Pharm Sci; 1992 Aug; 81(8):747-9. PubMed ID: 1403717
[TBL] [Abstract][Full Text] [Related]
24. The single-dose pharmacokinetics of NWP06, a novel extended-release methylphenidate oral suspension.
Childress AC; Berry SA
Postgrad Med; 2010 Sep; 122(5):35-41. PubMed ID: 20861586
[TBL] [Abstract][Full Text] [Related]
25. Determination of methylphenidate and its metabolite ritalinic acid in urine by liquid chromatography/tandem mass spectrometry.
Paterson SM; Moore GA; Florkowski CM; George PM
J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Jan; 881-882():20-6. PubMed ID: 22204874
[TBL] [Abstract][Full Text] [Related]
26. A Single-Dose, Single-Period Pharmacokinetic Assessment of an Extended-Release Orally Disintegrating Tablet of Methylphenidate in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
Childress A; Newcorn J; Stark JG; McMahen R; Tengler M; Sikes C
J Child Adolesc Psychopharmacol; 2016 Aug; 26(6):505-12. PubMed ID: 27228207
[TBL] [Abstract][Full Text] [Related]
27. A PET study examining pharmacokinetics and dopamine transporter occupancy of two long-acting formulations of methylphenidate in adults.
Spencer TJ; Bonab AA; Dougherty DD; Martin J; McDonnell T; Fischman AJ
Int J Mol Med; 2010 Feb; 25(2):261-5. PubMed ID: 20043136
[TBL] [Abstract][Full Text] [Related]
28. Pharmacokinetics of methylphenidate after oral administration of immediate and sustained-release preparations in Beagle dogs.
Lavy E; Prise U; Soldani G; Neri D; Brandriss N; Bar Chaim A; Giorgi M
Vet J; 2011 Sep; 189(3):336-40. PubMed ID: 20696604
[TBL] [Abstract][Full Text] [Related]
29. A single-dose, two-way crossover, bioequivalence study of dexmethylphenidate HCl with and without food in healthy subjects.
Teo SK; Scheffler MR; Wu A; Stirling DI; Thomas SD; Stypinski D; Khetani VD
J Clin Pharmacol; 2004 Feb; 44(2):173-8. PubMed ID: 14747426
[TBL] [Abstract][Full Text] [Related]
30. Single-Dose Pharmacokinetics of HLD200, a Delayed-Release and Extended-Release Methylphenidate Formulation, in Healthy Adults and in Adolescents and Children with Attention-Deficit/Hyperactivity Disorder.
Childress A; Mehrotra S; Gobburu J; McLean A; DeSousa NJ; Incledon B
J Child Adolesc Psychopharmacol; 2018 Feb; 28(1):10-18. PubMed ID: 29039979
[TBL] [Abstract][Full Text] [Related]
31. Determination of methylphenidate in plasma and saliva by liquid chromatography/tandem mass spectrometry.
Seçilir A; Schrier L; Bijleveld YA; Toersche JH; Jorjani S; Burggraaf J; van Gerven J; Mathôt RA
J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Apr; 923-924():22-8. PubMed ID: 23454305
[TBL] [Abstract][Full Text] [Related]
32. Analysis of methylphenidate and its metabolite ritalinic acid in monkey plasma by liquid chromatography/electrospray ionization mass spectrometry.
Doerge DR; Fogle CM; Paule MG; McCullagh M; Bajic S
Rapid Commun Mass Spectrom; 2000; 14(8):619-23. PubMed ID: 10786896
[TBL] [Abstract][Full Text] [Related]
33. Dose-proportional pharmacokinetics of d-threo-methylphenidate after a repeated-action release dosage form.
Tuerck D; Appel-Dingemanse S; Maboudian M; Pommier F; Wang Y; Sedek G
J Clin Pharmacol; 2007 Jan; 47(1):64-9. PubMed ID: 17192503
[TBL] [Abstract][Full Text] [Related]
34. Kinetic analysis of enantiomers of threo-methylphenidate and its metabolite in two healthy subjects after oral administration as determined by a gas chromatographic-mass spectrometric method.
Aoyama T; Kotaki H; Honda Y; Nakagawa F
J Pharm Sci; 1990 Jun; 79(6):465-9. PubMed ID: 2395090
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics, dose-range, and mutagenicity studies of methylphenidate hydrochloride in B6C3F1 mice.
Manjanatha MG; Shelton SD; Dobrovolsky VN; Shaddock JG; McGarrity LG; Doerge DR; Twaddle NW; Lin CJ; Chen JJ; Mattison DR; Morris SM
Environ Mol Mutagen; 2008 Oct; 49(8):585-93. PubMed ID: 18618596
[TBL] [Abstract][Full Text] [Related]
36. Application of Physiologically Based Absorption Modeling to Characterize the Pharmacokinetic Profiles of Oral Extended Release Methylphenidate Products in Adults.
Yang X; Duan J; Fisher J
PLoS One; 2016; 11(10):e0164641. PubMed ID: 27723791
[TBL] [Abstract][Full Text] [Related]
37. Differences in the in vitro and in vivo pharmacokinetic profiles of once-daily modified-release methylphenidate formulations in Canada: examination of current bioequivalence criteria.
Shram MJ; Quinn AM; Chen N; Faulknor J; Luong D; Sellers EM; Endrenyi L
Clin Ther; 2012 May; 34(5):1170-81. PubMed ID: 22512898
[TBL] [Abstract][Full Text] [Related]
38. Influence of ethanol on the pharmacokinetics of methylphenidate's metabolites ritalinic acid and ethylphenidate.
Koehm M; Kauert GF; Toennes SW
Arzneimittelforschung; 2010; 60(5):238-44. PubMed ID: 20533759
[TBL] [Abstract][Full Text] [Related]
39. Single-dose pharmacokinetics of methylphenidate extended-release multiple layer beads administered as intact capsule or sprinkles versus methylphenidate immediate-release tablets (Ritalin(®)) in healthy adult volunteers.
Adjei A; Teuscher NS; Kupper RJ; Chang WW; Greenhill L; Newcorn JH; Connor DF; Wigal S
J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):570-8. PubMed ID: 25514542
[TBL] [Abstract][Full Text] [Related]
40. Plasma Methylphenidate Levels in Youths With Attention Deficit Hyperactivity Disorder Treated With OROS Formulation.
Yorbik O; Mutlu C; Ozilhan S; Eryilmaz G; Isiten N; Alparslan S; Saglam E
Ther Drug Monit; 2015 Jun; 37(3):347-52. PubMed ID: 25384118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
